Sign In

ACS News

News

Breaking News

New rule set by the FDA goes into effect Tuesday

​Mammogram providers must notify patients and referring physicians about breast density.

Last year, the U.S. Food and Drug Administration (FDA) published updates to the mammography regulations that included requiring mammography facilities to notify patients about the density of their breasts. Beginning Sept. 10, 2024, mammography facilities must provide all patients receiving a mammogram with one of two Federal breast density notification statements (either “not dense” or “dense”). Additionally, the mammogram report sent to referring providers must include an assessment of the patient’s breast density. 

The ACS and ACS CAN released a joint statement last year commending the FDA for taking steps to modernize the Mammography Quality Standards Act (MQSA) which will help reduce breast cancer mortality. 

Breast density is important for two main reasons:

  • Women who have dense breast tissue have a higher risk of breast cancer compared to women with less dense breast tissue. It’s unclear at this time why dense breast tissue is linked to breast cancer risk. It may be that dense breast tissue has more cells that can develop into abnormal cells.
  • Dense breast tissue also makes it harder for radiologists to see cancer on mammograms. Dense (fibrous and glandular) breast tissue looks white on a mammogram. Breast masses and cancers can also look white, so the dense tissue can make it harder to see them. In contrast, fatty tissue looks almost black on a mammogram, so it’s easier to see a tumor that looks white if most of the breast is fat tissue.

Patient access to information about the impact that breast density and other factors can have on the risk for developing breast cancer is an important part of a comprehensive breast health strategy. 

ACS has extensive information on breast density on cancer.org and plans to produce an educational video that will be out in time for the rule to go into effect. A flyer is also available on Brand Central.



  • September Advocacy Update

    ​Highlights include ACS CAN's Leadership Summit and Lobby Day, Cancer Votes, and Lights of Hope.

    A message from ACS CAN President Lisa Lacasse

    ACS CAN's Leadership Summit and Lobby Day (LS&LD) is just around the corner, and this year, we are proud to host our largest event yet! From September 15-18th, we will welcome close to 750 advocates from across the country for dynamic days of training and advocacy in our nation's capital. 

    LS&LD provides an opportunity to unite nationwide volunteers and invest in their advocacy skills development and knowledge of our key priorities. It also builds strategic momentum toward our federal legislative agenda, elevating specific requests for every member of Congress on Lobby Day. Our priority asks of Congress this year focus on increasing cancer research funding and supporting bipartisan, bicameral multi-cancer early detection (MCED) legislation. Additionally, volunteers will note ACS CAN's support of extending critical Affordable Care Act enhanced tax credits that are set to expire in 2025. These enhanced tax credits currently make health care insurance more affordable for millions.

    LS&LD will kick off Sunday, September 15, starting with Affinity Row, an opportunity for ACS CAN volunteer affinity groups to show the impact they've been making across the country and introduce themselves to new volunteers. Please be sure to visit – there's much to learn from these volunteer communities who are working to ensure ACS CAN engages everyone in the fight against cancer. That evening, we will celebrate awardees at our annual National Advocacy Leadership Awards Dinner, honoring the remarkable work of our volunteers and colleagues since last September. 

    On Monday, we dive into our Leadership Summit: a full day of keynotes, general sessions, and breakouts to prepare for Hill visits with lawmakers urging support for our key "asks" for this year. The annual CAN Opener, our ticketed dinner and dancing fundraiser, is on Monday night; if you haven't yet bought your ticket, please do so here. 

    Tuesday is prime time as we execute our Lobby Day, heading to Capitol Hill to elevate our issues in Congressional offices with the mighty power of our blue shirts! That night, participants will gather to honor and remember our loved ones during our display of Lights of Hope at Constitution Gardens on the National Mall. Finally, on Wednesday, we will round out with the President's Recognition Ceremony and closing sessions. 

    We are honored to have special guests joining us, including this year's keynote speaker, author, artist, advocate, and cancer survivor Suleika Jaouad, NCI Director Dr. Kimryn Rathmell, National Distinguished Advocacy Award (NDAA) winners, Sen. Shelley Moore Capito (R-WV), MN Attorney General Keith Ellison (D) and CO Lt. Governor Dianne Primavera (D).

    I invite you to follow along with what will be an impactful few days in the fight against cancer by searching #CancerLobbyDay and #LightsOfHope on social media. Please be sure to amplify on your channels. I look forward to sharing highlights in a Special Edition Update and seeing those traveling to D.C. in less than two weeks. 

    Thanks as always for your support.

    Cancer Votes Update: 

    New Poll: As part of our national Cancer Votes campaign, ACS CAN released a poll this month showing inflation and the cost of living was the most important issue on voters' minds, with the affordability of health insurance being the top health care issue. A majority of voters said they would be more likely to vote for a candidate who supported policies requiring health plans to cover cancer screenings with no out-of-pocket costs. Voters also expressed concerns about the costs of medical debt, with 53% reporting that they or an immediate family member currently has medical debt.

    The poll findings also showed that 78% of voters were more likely to vote for a candidate who supported making permanent the Affordable Care Act's (ACA) enhanced tax credits. The policy proposal had the support of majorities of registered Republican, Independent and Democrat respondents. Public Opinion Strategies and Hart Research conducted the poll. Read our full release.

    Candidate Coffee Chats: In Nevada, Cancer Votes volunteers hosted a coffee chat with U.S. Senator Jacky Rosen (D) in partnership with Mi Familia Vota, an organization with the mission of building Latino voting power. Watch this video recap from a volunteer, Samantha Gonzales-Russell, who attended the event. Samantha and our Cancer Votes National Ambassador, Phil O'Brien were also featured in a TV interview about our latest poll. 

    In New Jersey, Cancer Votes volunteers hosted coffee chats with the candidates for New Jersey's 7th Congressional District, Susan Altman (D) and Congressman Tom Kean (R). And in New York, Cancer Votes volunteers hosted coffee chats with the candidates for New York's 17th Congressional District, Mondaire Jones (D) and Congressman Mike Lawler (R). ACS CAN Board Vice Chair, John Manna, moderated the discussions. 

    In Case You Missed It: 

    Lights of Hope 2024 fundraisers have been hard at work around the country. For those new to ACS CAN, each Light of Hope represents a loved one's cancer story—a survivor, someone in treatment, someone who passed from cancer, or a cancer caregiver. This event is a visual reminder to all elected officials of the strength of our collective voice and our role in this cancer fight – as well as a critical fundraiser for ACS CAN's public policy advocacy agenda. We are grateful to every volunteer participating! 

    You can still get involved by raising funds and donating to Lights of Hope.

    Catch the replay of our In Due Season screening hosted by the ACS CAN Black Volunteer Caucus. Thanks to all who joined the first nationwide virtual screening of In Due Season and virtual panel. Our partner Fenika Miller, Deputy National Field Director for Black Voters Matter, joined the panel discussion in addition to filmmaker Ashley O'Shay, Pam Williams, featured in the film, our host ACS CAN Board Chair Dr. Kimberly Jeffries Leonard, and ACS CAN Board member Dr. Karen Winkfield. The panel led a robust discussion about the film and the work ACS CAN is doing to pass policies to expand Medicaid in the ten states that haven't yet expanded. Visit In Due Season's website to watch and share the film, host a film screening, and take action.

    Social Spotlight: Share our August Volunteer Spotlight featuring Michael Hu, a Pennsylvania ACS CAN Legislative Ambassador. Michael was diagnosed with stage 4 lung cancer in March 2022. "One of the reasons I got involved [with ACS CAN] was [because] cancer took away a lot from me, and being able to do something that helps others made me feel empowered again," said Michael.

    MCED Push: There's still time to share our social media infographic about the significance of multi-cancer early detection by sharing posts on LinkedIn and Instagram.

    Judicial Update: 

    ACS CAN and its tobacco control partners filed an amicus brief urging the U.S. Supreme Court to uphold the Food and Drug Administration's (FDA) issuance of marketing denial orders for flavored e-cigarette products in a landmark case that will decide whether the agency can rein in the products and protect kids from a lifetime of addiction to nicotine. Read our full release.

    Advocacy in the News

    • MSNBC: Opinion: Biden’s right that we need new innovations in cancer care. Here’s what we need more.
    • Forbes: Feds Award Up To $150 Million To 8 Research Teams To Improve Cancer Surgeries
    • AP: Biden announces $150 million in research grants as part of his ‘moonshot’ push to fight cancer
    • Roll Call: Biden announces $150 million ‘Cancer Moonshot’ investment
    • Gray TV: President Biden, First Lady Jill Biden to fly to New Orleans on Tuesday for cancer initiative event
    • Stat : With Biden’s departure in sight, advocates seek to preserve gains of Cancer Moonshot
    • Self: What Losing a Testicle to Cancer Taught Me About Masculinity
    • CNN: Stop & Shop will join other major chains and stop selling cigarettes
    • Imperial Valley Press: Congressman Raul Ruiz holds joint conference in support of Clinical Trials for patients
    • Idaho Capital Sun: Without Idaho Medicaid expansion, ‘I may not be here.’ Documentary to share stories
    • Star City News : Hometown Hero: Christine Yoder


  • ACS CAN to host 18th annual Leadership Summit & Lobby Day

    ​More than 700 cancer patients, survivors, and their loved ones will travel to Washington, D.C.

    From Sept. 15 to 18, more than 700 cancer patients, survivors, and their loved ones will travel to Washington, D.C., for the American Cancer Society Cancer Action Network’s (ACS CAN) annual Leadership Summit & Lobby Day (LS&LD). ACS CAN advocates representing all 50 states, Washington, D.C., Guam and Puerto Rico, and nearly every congressional district will convene on Capitol Hill to ask Congress to make the fight against cancer a national priority. Photos above are from last year's event. 

    Schedule of Events

    Sunday, Sept. 15

    Volunteers will reach their destination at the Grand Hyatt Washington Hotel in D.C. on Sunday in time to attend meet and greet opportunities, such as discussions with ACS CAN’s Volunteer Affinity Groups, visiting the New Volunteer Welcome and the Ask Lounge and attending the annual ACS CAN National Advocacy Leadership Awards Dinner – where dedicated ACS CAN volunteers and team members will be recognized for their outstanding work in cancer advocacy. Check ACS2Go and Society Source on Monday, Sept. 16 for a full list of award recipients.  

    Monday.Sept. 16

    Advocates will spend Monday in breakout and training sessions to prepare for lawmaker meetings on Tuesday. The day will conclude with festivities at the CAN Opener Dinner and Dancing Celebration from 6 p.m. until 8:30 p.m., an annual fundraiser for ACS CAN, open to ticket holders (see below).

    CAN Opener Party

    This year’s theme, “To Boldly Go Where No Cancer Advocates Have Gone Before,” provides attendees with a fun opportunity to get a little creative and come dressed in their favorite space-themed attire. There will be a sit-down dinner, live DJ, photobooth and much more. To purchase a $60 ticket online, visit 2024 CAN Opener at fightcancer.org by Sept. 12. Tickets will also be available onsite by the LS&LD registration table on Sept. 15 from 12 noon until 3 p.m. for $70. If you or someone you know would like to attend the CAN Opener, but cannot afford the ticket price, please contact ACS CAN Associate Director of Distinguished Events Chelsea Herman.

    ACS CAN Silent Auction 

    ACS CAN’s Online Silent Auction will be held Sept. 11 until Monday Sept. 16, with items collected and/or donated by ACS CAN staff and volunteers nationwide. Bidding is open to everyone and is not restricted to those attending LS&LD. Examples of donated items include, ACS CAN branded items, signed memorabilia, sweet treats, jewelry, gift baskets and much more. ACS CAN’s Online Silent Auction website will go live on Sept. 11 to preview available items. The online auction will close after the CAN Opener Celebration on Sept. 16 at 8:40 p.m. ET. For additional information, contact ACS CAN Senior Development Manager Molly Waite.

    Tuesday, Sept. 17

    On Sept. 17, ACS CAN volunteers will kick off the “Lobby Day” portion of LS&LD by asking members of Congress to: 

    • Support the highest possible increases for cancer research with $51.3 billion for the National Institutes of Health (NIH), including $ 7.934 billion for cancer research at the National Cancer Institute (NCI), and $1.5 billion for the Advanced Research Projects Agency for Health (ARPA-H). Also requesting $472.4 million for the Centers for Disease Control and Prevention’s (CDC) cancer programs, including $230 million for the National Breast and Cervical Cancer Early Detection Program.
    • Support final passage of H.R. 2407/S. 2085, the Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act. This legislation will create a pathway for Medicare coverage of multi-cancer screening tests once they are approved by the FDA and clinical benefit has been shown.

    ACS CAN will also honor federal lawmakers and others who have made exemplary contributions to the cancer fight with its annual National Distinguished Advocacy Award (NDAA) presentation. This year’s recipients are U.S. Senator Shelley Moore Capito (R-West Virginia) and U.S. Representative Raul Ruiz (D-California). 

    Beginning at 7 p.m. ET, ACS CAN will host its annual Lights of Hope Walk, a solemn display featuring nearly 10,000 lights at Constitution Garden on the National Mall, and state columns honoring cancer survivors and memorializing those who have died from the disease. Nearly 65,000 additional bags will be on display at similar events nationwide.

    Wednesday. Sept. 18

    LS&LD will conclude on Wednesday with a keynote address from Suleika Jaouad, Emmy award-winning New York Times author, artist, advocate and cancer survivor. ACS CAN’s annual President’s Recognition Ceremony will start the morning, with awards recognizing lawmakers and pro bono legal work, followed by recognition of the top 10 volunteers who raised the most funds for Lights of Hope. 

    State and local NDAA recipients Colorado Lieutenant Governor Dianne Primavera, Minnesota Attorney General Keith Ellison, along with Pennsylvania State Senator Devlin Robinson, will be honored for their commitment in the fight against cancer for everyone. 

    ACS CAN will also present the Judicial Advocacy Initiative (JAI) award, which recognizes excellence in attorneys who donate services to the cancer fight to support its mission.

    Stay Connected

    All team members are encouraged to follow Leadership Summit & Lobby Day activities on social media. Live updates and photos will be shared throughout the week with the #CancerLobbyDay and #LightsofHope hashtags. Please be sure to amplify on your own channels.

    Check Society Source and ACS2Go and ACS CAN President Lisa Lacasse’s X account @LLacasseACSCAN for updates throughout the week.

    In addition to accessing the event website, registered participants can also reference the LS&LD event app to stay up to date with content and view event materials and helpful resources.

    ​

  • National meeting focuses on the future

    ​ACS National Roundtable on Cervical Cancer launches data dashboard.

    On Aug. 22, the American Cancer Society National Roundtable on Cervical Cancer (ACS NRTCC) welcomed 237 attendees to their virtual national meeting, including clinicians, academic researchers, advocacy and health care industry partners, and tribal organizations.

    Themed "Force of the Future," the meeting featured sessions on self-collection for cervical cancer screening, creating trusted messaging, and opportunities to engage with subject matter experts.

    During the event, ACS NRTCC launched their new resource, the ACS NRTCC Cervical Cancer Data Dashboard, an interactive tool providing a geospatial view of cervical cancer data across the US, including screening rates, National Breast and Cervical Cancer Early Detection Program (NBCCEDP) locations, and demographics. Participants were challenged to share the news during the meeting, and they met that challenge with more than 1,000 partners reached in 24 hours! Congratulations on this successful endeavor.

    Explore the Data Dashboard

    Next up will be ACS NRTCC’s Patient Education webinar series, launching on Sept. 18. Sign up for the roundtable’s newsletter to stay in the loop about upcoming webinars and resource releases. 

    Social media graphic with headshots of women and text 



  • Affordability of health insurance is top health care issue, ACS CAN poll shows

    ​Voters also expressed concerns with the costs of medical debt.

    A recent poll by the American Cancer Society Cancer Action Network (ACS CAN) showed that inflation and the cost of living was the most important issue on voters’ minds with the affordability of health insurance being the top health care issue. Read the full polling memo.

    A majority of voters said they would be more likely to vote for a candidate who supported policies requiring health plans to cover cancer screenings with no out-of-pocket costs.

    Voters also expressed concerns with the costs of medical debt with 53% reporting that they or an immediate family member currently have medical debt.

    The poll findings also showed 78% of voters were more likely to vote for a candidate who supported making permanent the Affordable Care Act’s (ACA) enhanced tax credits. The policy proposal had the support of majorities of Republican, Independent and Democrat respondents.

    Conducted by Public Opinion Strategies and Hart Research, this poll is a part of ACS CAN’s national Cancer Votes campaign—the country’s leading voter education program for cancer-related issues and policies.

    “Having access to affordable health insurance coverage is a key determinant for surviving cancer,” said ACS CAN President Lisa A. Lacasse. “Research shows that uninsured Americans are less likely to get screened for cancer and thus are more likely to have their cancer diagnosed at an advanced stage when survival is less likely and the cost of care more expensive. ACS CAN strongly advocates for public policies, like making permanent the ACA’s enhanced tax credits, to make insurance more affordable for people to get the coverage they need.”

    As part of the American Rescue Plan Act enacted in March 2021, Congress made two temporary, but major changes to the ACA tax credits for marketplace plans: it increased the amount of the tax credit for those between 133%-400% FPL; and extended the eligibility for the tax credits to those earning beyond 400% FPL. The ACA enhanced tax credits allow more people to purchase comprehensive health insurance coverage and contributed to historic enrollment in Marketplace plans after they took effect. The ACA enhanced tax credits are set to expire in 2025 unless Congress extends them again or makes them permanent. If they expire, millions will lose access to the affordable, quality health coverage they rely on.

    “Fighting cancer must be made a national priority,” said Phil O'Brien, ACS CAN Cancer Votes National Ambassador. “Lawmakers have the power to directly impact the lives of millions of cancer patients and their families, which is why we hope that the candidates will go on the record with their positions on these critical issues and we urge the public to know where candidates stand on these issues before they vote.”

    ACS CAN is strictly nonpartisan and does not endorse, oppose, or contribute to any candidate or political party. For more information, visit cancervotes.org.


  • ACS partners with Giving Docs during National Make-A-Will month

    ​ACS team members and supporters are eligible for this free service.​

    August is National Make-A-Will month, and the American Cancer Society recently launched a new partnership with Giving Docs, which offers free will development, among other estate planning services. ACS team members and supporters can take advantage of this free service and quickly create (or update) a legally binding will, durable power of attorney and/or advance medical directive with zero cost or obligation. This resource is also unique in that it provides the option to leave a gift for the American Cancer Society, if inspired to do so.

    “About 67% of Americans die in testate, meaning they do not have a will. We often hear the common perception that creating a will is expensive, time-consuming, or emotionally challenging for individuals,” said Bobby Collier, senior vice president, Planned Giving. “This partnership between ACS and Giving Docs will help to overcome these barriers and allow ACS supporters to advance the values most important in their lives by providing a gift through estate planning.” 

    This opportunity is not limited to the month of August and anyone who is interested is encouraged to visit the Giving Docs website to get started. 

    “My husband and I put off creating a will mainly due to the cost quoted by our financial planner, which was more than $3,000. When I found out about the new opportunity through Giving Docs I immediately signed up,” said Lisa Bishop, managing director, Region Philanthropy. "The Giving Docs software was so easy to understand and navigate as we were creating the documents. I would recommend this benefit to anyone who has been putting off planning for the future and ensuring that your assets, and your family, are taken care of!”

    For more information about Planned Giving and estate planning, or to contact someone at ACS about these topics, visit cancer.org. 

    ​

  • NBA star Alonzo Mourning headlines Prostate Cancer Awareness Month

    ​Know Your Score campaign launches.​

    During Prostate Cancer Awareness Month this September, the American Cancer Society is raising awareness about the importance of timely prostate cancer screening. Leading with a sports-focused message to men to “Know Your Score”, the integrated campaign seeks to motivate men to ask a doctor about prostate cancer screening.

    Our MVP Survivor, Thanks to Screening

    Former National Basketball Association (NBA) player and Basketball Hall of Famer Alonzo Mourning, pictured above, will be featured in this year’s campaign. Alonzo was diagnosed with stage III prostate cancer early in 2024. He had surgery in March 2024 and is now cancer free. He is determined to advocate for men to ask a doctor about prostate cancer screening.

    Here's what you should know: 

    • Cancer screening is for people without symptoms. Prostate cancer screening can help find cancer early, when it may be easier to treat.  
    • The number of advanced stage prostate cancer diagnoses is increasing, after decades of decline.
    • At age 50, men at average risk should talk to a health care provider about prostate cancer screening. Men at increased risk of developing cancer should have that conversation earlier than age 50. (Prostate Cancer Screening Guidelines)
    • Studies show that nearly 2/3 of men age 55 – 69 are not being screened for prostate cancer.
    • In 2024, an estimated 299,010 new cases of prostate cancer will be diagnosed in the US and 35,250 men will die from the disease. 
    • The incidence of prostate cancer is about 70% higher in Black men than in White men for reasons that remain unclear.
    • Prostate cancer has the greatest mortality disparities of any cancer.
    • Black men have a higher risk of developing prostate cancer. They are also more likely to be diagnosed at an advanced stage and have a higher mortality rate compared to other racial and ethnic groups.

    Call to Action: Visit cancer.org/getscreened to learn more and find a screening location near you.

    Here’s what you can do: 

    • Visit http://cancer.org/getscreened to learn more about prostate cancer screening and check out the video from Alonzo Mourning!
    • Amplify social content on the ACS brand channels featuring prostate cancer awareness and screening messages.

    ACS IMPACT Initiative 

    ACS is addressing and hoping to reverse these trends with its IMPACT initiative – Improving Mortality from Prostate Cancer Together. By leveraging our strengths across our mission pillars (discovery, patient support, and advocacy) and our efforts to promote diversity, equity, and inclusion, we will ensure everyone has the same opportunity to be healthy and cancer-free.

    Black men have a higher risk of developing prostate cancer. They are also more likely to be diagnosed at an advanced stage and have a higher mortality rate compared to other racial and ethnic groups.

    Prostate Cancer Roundtable in September

    The ACS will launch the National Prostate Cancer Roundtable (NPCRT) on Sept. 5 in Washington, D.C. The NPCRT joins the other six roundtables led by the American Cancer Society. Stay tuned to ACS2Go for upcoming details. 



  • Volunteer Engagement Survey identifies key strengths and opportunities

    ​Participation in 2023 annual survey grew 4% over previous year.​​​

    Many thanks to the more than 3,350 volunteers who took time to provide feedback by participating in the 2023 Volunteer Engagement survey, which is issued to a select group of committed volunteers each fall.

    “Survey participation increased by 4% year-over-year (YOY) and we hope that continues to grow,” said Ashley Merritt, senior director, Volunteer Experience. “We are committed to sharing these key learnings with our surveyed volunteers and building action plans to help address areas of opportunity to strengthen volunteer engagement across ACS and ACS CAN.” 

    For overall audience, some of the key findings include:

    • “Clarity of ACS priorities,” a key engagement driver, continues to increase (+4% YOY)
    • “Proud to work at ACS” (95%) and “Support ACS values” (93%) are the most agreed upon statements among volunteer leaders.
    • “I feel my voice is heard” remains flat at 82% for total volunteer leadership, pointing to an area of opportunity to strengthen and grow our engagement.
    • However, “I feel my voice is heard” increased 4% points among Event Leadership Team volunteers (78%), indicating that progress is being made for this segment of leaders. 

    For ACS CAN volunteer leaders, we saw positive movement across three important metrics:

    • “I feel my voice is heard” (83%)
    • “I can be successful” (88%)
    • “I am motivated by ACS priorities” (93%)

    Area board ranking improved for “I feel my voice is heard” but declined in other key drivers like “I feel recognized” and “I am making a difference” (both down 3% points), which are drivers the organization will focus on at the region level.

    As a next step, ACS leaders will take a deeper dive into role and geography specific survey data to glean additional insights that can help inform action plans to support and address our greatest opportunities. Consider this survey as part of an ongoing conversation between ACS and our volunteer leaders. If you have additional suggestions, feedback, or ideas we would love to hear from you. Please feel free to reach out to our volunteer engagement team via a secure inbox at VolunteerEngagement@cancer.org.



  • ACS Hematologic Cancer Collaborative convenes

    ​Cross-enterprise effort to tackle blood cancer challenges.

    On Aug. 20, the National Roundtables & Coalitions business unit of the Patient Support Pillar hosted the ACS Hematologic Cancer Collaborative Summit in Washington, D.C., bringing together expert clinicians, researchers, advocacy and industry partners to further our efforts to address pressing issues in the hematologic cancer space. 

    This was the third of four meetings for this group, who convened virtually in June and July and who will meet again virtually in October. 

    At the in-person Summit, 26 participants engaged in meaningful discussion, building on insights shared prior through virtual meetings and participant surveys.

    Participants spent the day ideating and prioritizing feasible strategies to tackle challenges facing the blood cancer community, with discussions focused on three priority areas: addressing equitable access, managing complexities, and enhancing the blood cancers care experience.

    The energy throughout the day was upbeat and aspirational, and participants were passionately engaged and appreciative for the opportunity to collaborate.
back to top